ArticleCureus2024
Trends in the Epidemiology of Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Surgery.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The incidence and associated factors of pulmonary embolism after cardiac surgery: A retrospective nationwide inpatient sample database study.American heart journal plus : cardiology research and practice · 2026Article
- Preventive Strategies for Upper Extremity Deep Venous Thrombosis Following Elective Upper Limb Surgery: A Systematic Review.Clinics and practice · 2025Review
- Targeting toll-like receptors: unveiling potential therapeutic strategies for deep vein thrombosis.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aims to utilize the TriNetX database, a comprehensive global network, to improve our understanding of the frequency, demographic factors, and related comorbidities of surgical patients who develop venous thromboembolism (VTEs) events. Methods The global collaborative network in TriNetX was queried for all cases from January 1, 2017, through December 31, 2023. International Classification for Disease (ICD) diagnosis codes were used to define patient cohorts with deep vein thrombosis (DVT) of the upper or lower extremity or pulmonary embolism (PE). Patient information was extracted including age, sex, ethnicity, race status, and comorbidities. We assumed that PE occurred following a DVT which is only reported once as a PE, and not a DVT. Results The study included 414,045 patients with lower extremity DVT, 82,800 with upper extremity DVT, and 508,044 with reported PE following a DVT. DVT and PE account for approximately 51% and 49% of VTE cases, respectively, with differences noted based on age, sex, ethnicity, race, and comorbidities. The data showed that advanced age, higher BMI, and Black race are associated with a higher risk of thromboembolism. Common comorbidities, such as cardiac dysrhythmias, a history of thromboembolism, cancer, and renal failure are prevalent across all three diagnostic groups. Conclusion The study results suggest that the incidence and prevalence of VTE are changing due to the aging population and changes in demographic patterns. Healthcare services should consider planning for the changes in morbidity, mortality, and related healthcare costs. Surgical patients with multiple related comorbidities should be managed to prevent VTEs more aggressively with close monitoring for any evolving VTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.